PF-3450074 T16500
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PF-3450074 acts at an early stage of HIV-1 infection inhibits viral replication by directly competing with the binding of CPSF6 (nuclear host factors cleavage and polyadenylation specific factor 6) and NUP153 (nucleoporin 153), and blocks the uncoating, a
CAS nr:
1352879-65-2
Purity:
98%
Molecular Weight:
425,52
SMILES:
O=C(N[C@@H](CC1=CC=CC=C1)C(N(C)C2=CC=CC=C2)=O)CC3=C(C)NC4=C3C=CC=C4
Formula:
C27H27N3O2
Pathway:
Proteases/Proteasome,Microbiology/Virology
Target:
HIV Protease,HIV Protease
